Buergli Pharma

Bürgli Pharma AG is a Swiss specialty pharmaceutical company focused on the development, registration, and distribution of niche therapeutic products and value-added medicines. The company is a leading provider in the field of Opioid Substitution Therapy (OST) in Switzerland, offering a specialized portfolio that includes methadone, morphine, and buprenorphine formulations. Beyond addiction medicine, Bürgli Pharma provides high-quality generics and specialty products in areas such as pain management and mineral supplementation. Headquartered in Baar, the company manages the entire lifecycle of its products, from regulatory affairs and market access to supply chain management. Bürgli Pharma is recognized for its commitment to ensuring the availability of essential medications for specialized patient populations within the Swiss healthcare system.